A study in glioma demonstrated that high levels of IRAK1 bound to and prevented the degradation of PRDX1, a major member of antioxidant enzymes, in glioma cells, leading to the suppression of autophagic cell death and development of radioresistance. This evidence concerns the gene PRDX1 and central nervous system cancer.